NCCN Guidelines for Patients® | Melanoma

3 NCCN Guidelines for Patients ® : Melanoma, 2018  Endorsed by Supporter Endorsed by AIM at Melanoma Every hour someone in the United States dies from melanoma, the deadliest form of skin cancer. If caught in its early stages, chances of survival are excellent. However, once it has spread, survival rates drop dramatically. The NCCN Guidelines are an important tool for patients with melanoma to help educate them on the treatment options that are available for melanoma patients as well as follow-up care which is essential for their future health. Melanoma Research Alliance The MRA endorses the NCCN Guidelines for Patients with Melanoma. This is an important resource to assist patients or caregivers in understanding the treatment approaches available and the progress against this terrible disease. Melanoma Research Foundation (MRF) The Melanoma Research Foundation is very pleased to endorse the NCCN Guidelines for Patients, which provide people who are living with cancer the same information that for years has informed doctors about the current best practices in care. We believe that informed and empowered patients live longer, better lives and this information is critical in a time when the treatment landscape is changing so rapidly.